Latest round: IPO. Sekar Kathiresan is a physician-scientist, human geneticist, Co-founder, and Chief Executive Officer of Verve Therapeutics.
Sekar Kathiresan is a physician-scientist, human geneticist, Co-founder, and Chief Executive Officer of Verve Therapeutics. The company is a clinical-stage biotechnology firm focused on developing gene editing medicines for cardiovascular disease. He leads efforts to create single-course gene editing treatments to permanently lower cholesterol.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide